In Issue 10 of Malignant Haematology Research Review: Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or...
Research Review
Multiple Myeloma Research Review
Multiple_Myeloma_Research_Review_Issue_43Download
Multiple Myeloma Research Review
Multiple_Myeloma_Research_Review_Issue_42Download
Myeloma Research Review – Issue 39
Welcome to issue 39 of Multiple Myeloma Research Review. This issue’s selection includes research reporting that switching elderly intermediate-fit...
Myeloma Research Review – Issue 37
Welcome to issue 37 of Multiple Myeloma Research Review. This issue begins with a retrospective, multinational report describing the clinical...
Myeloma Research Review – issue 36
Welcome to issue 36 of Multiple Myeloma Research Review. The use of ixazomib-based induction therapy in routine clinical practice is relatively...
Multiple Myeloma Research Review
Highlights include: Associations with OS in NZ MM patients VTE risk with lenalidomide regimens for MM despite thromboprophylaxis Retrospective study...
Multiple Myeloma Research Review
Highlights include: Daratumumab + standard care in newly diagnosed MM OS with daratumumab + bortezomib/melphalan/prednisone in newly diagnosed MM...
Multiple Myeloma Research Review
Highlights include: • Once-weekly vs twice weekly carfilzomib for newly diagnosed MM • Negative trials for pembrolizumab in treatment naive and...
Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand
The impact of age, ethnicity and socio-economic deprivation in the era of novel anti-myeloma agents is unclear. Using linked national data from New...
Multiple Myeloma Research Review
Highlights include: • Increased novel agent access in NZ improved MM survival • Pomalidomide-based regimens for relapsed/refractory MM •...
Multiple Myeloma Research Review
Highlights include: • Anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. • MGUS risk in relatives of patients with multiple...